Cargando…

The Prognostic Value of CD133 in Predicting the Relapse and Recurrence Pattern of High-Grade Gliomas on MRI: A Meta-Analysis

BACKGROUND: Cancer stem cells have been implicated in tumor relapse, tumor invasion, and cancer therapy resistance in high-grade gliomas; thus, characterizing cancer stem cell-related markers can help determine the prognosis of affected patients. Preclinical studies have reported that CD133 is impli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdoli Shadbad, Mahdi, Hosseinkhani, Negar, Asadzadeh, Zahra, Brunetti, Oronzo, Silvestris, Nicola, Baradaran, Behzad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445366/ https://www.ncbi.nlm.nih.gov/pubmed/34540691 http://dx.doi.org/10.3389/fonc.2021.722833

Ejemplares similares

A Systematic Review of the Tumor-Infiltrating CD8(+) T-Cells/PD-L1 Axis in High-Grade Glial Tumors: Toward Personalized Immuno-Oncology
por: Shadbad, Mahdi Abdoli, et al.
Publicado: (2021)

A Systematic Review to Clarify the Prognostic Values of CD44 and CD44(+)CD24(-) Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
por: Abdoli Shadbad, Mahdi, et al.
Publicado: (2021)

The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead
por: Hosseinkhani, Negar, et al.
Publicado: (2021)

A Systematic Review and Meta-Analysis on the Significance of TIGIT in Solid Cancers: Dual TIGIT/PD-1 Blockade to Overcome Immune-Resistance in Solid Cancers
por: Hosseinkhani, Negar, et al.
Publicado: (2021)

A scoping review on the significance of programmed death-ligand 1-inhibiting microRNAs in non-small cell lung treatment: A single-cell RNA sequencing-based study
por: Shadbad, Mahdi Abdoli, et al.
Publicado: (2022)

A Systematic Review on PD-1 Blockade and PD-1 Gene-Editing of CAR-T Cells for Glioma Therapy: From Deciphering to Personalized Medicine
por: Abdoli Shadbad, Mahdi, et al.
Publicado: (2022)

Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?
por: Hosseinkhani, Negar, et al.
Publicado: (2020)

Targeting TGF-β-Mediated SMAD Signaling Pathway via Novel Recombinant Cytotoxin II: A Potent Protein from Naja naja oxiana Venom in Melanoma
por: Derakhshani, Afshin, et al.
Publicado: (2020)

Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy
por: Fasano, Rossella, et al.
Publicado: (2021)

Photodynamic Therapy with Zinc Phthalocyanine Inhibits the Stemness and Development of Colorectal Cancer: Time to Overcome the Challenging Barriers?
por: Gholizadeh, Mahsa, et al.
Publicado: (2021)

Regulation of CTLA-4 and PD-L1 Expression in Relapsing-Remitting Multiple Sclerosis Patients after Treatment with Fingolimod, IFNβ-1α, Glatiramer Acetate, and Dimethyl Fumarate Drugs
por: Derakhshani, Afshin, et al.
Publicado: (2021)

Arginase 1 (Arg1) as an Up-Regulated Gene in COVID-19 Patients: A Promising Marker in COVID-19 Immunopathy
por: Derakhshani, Afshin, et al.
Publicado: (2021)

Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine
por: Derakhshani, Afshin, et al.
Publicado: (2021)

Identification of Common and Distinct Pathways in Inflammatory Bowel Disease and Colorectal Cancer: A Hypothesis Based on Weighted Gene Co-Expression Network Analysis
por: Derakhshani, Afshin, et al.
Publicado: (2022)

Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials
por: Kooshkaki, Omid, et al.
Publicado: (2020)

A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery
por: Shadbad, Mahdi Abdoli, et al.
Publicado: (2021)

From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past
por: Shadbad, Mahdi Abdoli, et al.
Publicado: (2021)

The Role of Hemoglobin Subunit Delta in the Immunopathy of Multiple Sclerosis: Mitochondria Matters
por: Derakhshani, Afshin, et al.
Publicado: (2021)

MicroRNAs and lncRNAs—A New Layer of Myeloid-Derived Suppressor Cells Regulation
por: Safarzadeh, Elham, et al.
Publicado: (2020)

The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in Gastric Cancer Treatment
por: Bolandi, Nadia, et al.
Publicado: (2021)

The expression pattern of Immune checkpoints after chemo/radiotherapy in the tumor microenvironment
por: Hassanian, Hamidreza, et al.
Publicado: (2022)

COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients?
por: Brunetti, Oronzo, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects
por: Makaremi, Shima, et al.
Publicado: (2021)

MiR-146a Restoration Suppresses Triple-Negative Breast Cancer Cell Migration: A Bioinformatic and In Vitro Study
por: Tebbi, Leila, et al.
Publicado: (2022)

Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis Study
por: Lotfinejad, Parisa, et al.
Publicado: (2020)

The Regulatory Cross-Talk between microRNAs and Novel Members of the B7 Family in Human Diseases: A Scoping Review
por: Ahangar, Noora Karim, et al.
Publicado: (2021)

The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme
por: Daei Sorkhabi, Amin, et al.
Publicado: (2022)

Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments
por: Kooshkaki, Omid, et al.
Publicado: (2020)

MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers
por: Kooshkaki, Omid, et al.
Publicado: (2020)

Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy
por: Amir Taghavi, Bita, et al.
Publicado: (2022)

Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death
por: Asadzadeh, Zahra, et al.
Publicado: (2020)

CTLA-4 silencing in dendritic cells loaded with colorectal cancer cell lysate improves autologous T cell responses in vitro
por: Ghorbaninezhad, Farid, et al.
Publicado: (2022)

From Oncogenic Signaling Pathways to Single-Cell Sequencing of Immune Cells: Changing the Landscape of Cancer Immunotherapy
por: Derakhshani, Afshin, et al.
Publicado: (2021)

The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic Cancers
por: Kooshkaki, Omid, et al.
Publicado: (2020)

COVID Vaccination in Cancer Patients: What Vaccination Priority Strategies Should There Be?
por: Silvestris, Nicola, et al.
Publicado: (2021)

Glial Progenitor-Like Phenotype in Low-Grade Glioma and Enhanced CD133-Expression and Neuronal Lineage Differentiation Potential in High-Grade Glioma
por: Rebetz, Johan, et al.
Publicado: (2008)

Radiosurgery and Stereotactic Brain Radiotherapy with Systemic Therapy in Recurrent High-Grade Gliomas: Is It Feasible? Therapeutic Strategies in Recurrent High-Grade Gliomas
por: Gregucci, Fabiana, et al.
Publicado: (2022)

Editorial: The Effect of the COVID-19 Pandemic on Cancer Patients and Healthcare
por: Silvestris, Nicola, et al.
Publicado: (2022)

Multimodal MRI-Based Radiomic Nomogram for the Early Differentiation of Recurrence and Pseudoprogression of High-Grade Glioma
por: Jing, Hui, et al.
Publicado: (2022)

Rules-based Volumetric Segmentation of Multiparametric MRI for Response Assessment in Recurrent High-Grade Glioma
por: Ravi, Harshan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ni3687ug11qjj16blevou6oavd